Literature DB >> 27221205

Standardisation and use of the alcohol biomarker carbohydrate-deficient transferrin (CDT).

Anders Helander1, Jos Wielders2, Raymond Anton3, Torsten Arndt4, Vincenza Bianchi5, Jean Deenmamode6, Jan-Olof Jeppsson7, John B Whitfield8, Cas Weykamp9, François Schellenberg10.   

Abstract

Carbohydrate-deficient transferrin (CDT) is a glycoform profile of serum transferrin that increases in response to sustained high alcohol intake and over the last decades has become an important alcohol biomarker with clinical and forensic applications. However, the wide range of CDT measurement procedures has resulted in lack of uniform results and reference limits, and hampered comparison of results. In 2005, the IFCC therefore founded a special working group (WG) aiming for standardisation of CDT measurement. This review summarises the history of CDT and the actions taken by the WG-CDT. Initial steps included the definition of the measurand (serum disialotransferrin to total transferrin fraction expressed in %), and the determination of a well-defined anion-exchange HPLC procedure as the candidate reference measurement procedure (cRMP). Subsequent achievements were the establishment of a network of reference laboratories to perform the cRMP, setting a reference interval, and development of a reference material based on human serum for which the laboratory network assign values. Using a set of reference materials for calibration allowed for achieving equivalence of results of all present CDT measurement procedures. The final steps of the WG-CDT have been a full validation of the cRMP to make it an IFCC approved RMP, and providing guidance for international standardisation of all CDT measurement procedures.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alcohol biomarker; CDT; Carbohydrate-deficient transferrin; HPLC; IFCC; Serum transferrin; Standardisation

Mesh:

Substances:

Year:  2016        PMID: 27221205     DOI: 10.1016/j.cca.2016.05.016

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  8 in total

1.  Brain Glutamate, GABA, and Glutamine Levels and Associations with Recent Drinking in Treatment-Naïve Individuals with Alcohol Use Disorder Versus Light Drinkers.

Authors:  James J Prisciandaro; Joseph P Schacht; Andrew P Prescot; Perry F Renshaw; Truman R Brown; Raymond F Anton
Journal:  Alcohol Clin Exp Res       Date:  2019-01-04       Impact factor: 3.455

2.  Relationship of Abnormal Chromatographic Pattern for Carbohydrate-Deficient Transferrin with Severe Liver Disease.

Authors:  Scott H Stewart; Adrian Reuben; Raymond F Anton
Journal:  Alcohol Alcohol       Date:  2016-10-07       Impact factor: 2.826

Review 3.  Iron and iron-related proteins in alcohol consumers: cellular and clinical aspects.

Authors:  Kevin Ferrao; Najma Ali; Kosha J Mehta
Journal:  J Mol Med (Berl)       Date:  2022-10-10       Impact factor: 5.606

4.  Intraindividual changes in brain GABA, glutamate, and glutamine during monitored abstinence from alcohol in treatment-naive individuals with alcohol use disorder.

Authors:  James J Prisciandaro; Joseph P Schacht; Andrew P Prescot; Helena M Brenner; Perry F Renshaw; Truman R Brown; Raymond F Anton
Journal:  Addict Biol       Date:  2019-08-01       Impact factor: 4.280

Review 5.  Consensus guideline for the diagnosis and management of mannose phosphate isomerase-congenital disorder of glycosylation.

Authors:  Anna Čechová; Ruqaiah Altassan; Delphine Borgel; Arnaud Bruneel; Joana Correia; Muriel Girard; Annie Harroche; Beata Kiec-Wilk; Klaus Mohnike; Tiffany Pascreau; Łukasz Pawliński; Silvia Radenkovic; Sandrine Vuillaumier-Barrot; Luis Aldamiz-Echevarria; Maria Luz Couce; Esmeralda G Martins; Dulce Quelhas; Eva Morava; Pascale de Lonlay; Peter Witters; Tomáš Honzík
Journal:  J Inherit Metab Dis       Date:  2020-04-21       Impact factor: 4.982

6.  Systematic review and meta-analysis of the moderating effect of rs1799971 in OPRM1, the mu-opioid receptor gene, on response to naltrexone treatment of alcohol use disorder.

Authors:  Emily E Hartwell; Richard Feinn; Paige E Morris; Joel Gelernter; John Krystal; Albert J Arias; Michaela Hoffman; Ismene Petrakis; Ralitza Gueorguieva; Joseph P Schacht; David Oslin; Raymond F Anton; Henry R Kranzler
Journal:  Addiction       Date:  2020-02-11       Impact factor: 6.526

7.  Elimination Characteristics of the Alcohol Biomarker Phosphatidylethanol (PEth) in Blood during Alcohol Detoxification.

Authors:  Anders Helander; Michael Böttcher; Norbert Dahmen; Olof Beck
Journal:  Alcohol Alcohol       Date:  2019-05-01       Impact factor: 2.826

8.  Alcohol consumption and employment: a cross-sectional study of office workers and unemployed people.

Authors:  Simone De Sio; Roberta Tittarelli; Giuseppe Di Martino; Giuseppe Buomprisco; Roberto Perri; Guglielmo Bruno; Flaminia Pantano; Giulio Mannocchi; Enrico Marinelli; Fabrizio Cedrone
Journal:  PeerJ       Date:  2020-03-24       Impact factor: 2.984

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.